Table 2 Patients’ background and measured parameters by gender
From: The factors driving self-efficacy in intractable chronic pain patients: a retrospective study
Total (n = 147) | Male (n = 35) | Female (n = 112) | p value | |
|---|---|---|---|---|
Age (years) | 71.2 ± 12.2 | 69.9 ± 12.7 | 71.6 ± 12.8 | 0.11 |
Pain duration (months) | 58.0 ± 92.7 | 44.1 ± 71.7 | 62.3 ± 98.2 | 0.39 |
PSEQ (points) | 35.0 ± 14.2 | 36.6 ± 13.4 | 30.0 ± 15.6 | 0.03* |
NRS (points) | 5.2 ± 1.9 | 5.7 ± 2.1 | 5.1 ± 1.8 | 0.16 |
PCS (points) | 26.4 ± 11.3 | 27.9 ± 10.3 | 25.9 ± 11.6 | 0.46 |
HADS anxiety (points) | 3.9 ± 3.3 | 4.2 ± 2.9 | 3.9 ± 3.4 | 0.29 |
HADS depression (points) | 4.7 ± 3.5 | 5.3 ± 3.5 | 4.4 ± 3.5 | 0.14 |
PDAS (points) | 20.6 ± 13.0 | 23.8 ± 15.7 | 19.6 ± 11.9 | 0.19 |
Pain site (number of patients) | ||||
Low back | 97 (66.0%) | 27 (77.1%) | 70 (62.5%) | 0.15 |
Knee | 71 (48.3%) | 13 (51.8%) | 58 (37.1%) | 0.13 |
Shoulder | 34 (23.1%) | 6 (17.1%) | 28 (25.0%) | 0.33 |
Hip | 15 (10.2%) | 2 (5.7%) | 13 (11.6%) | 0.31 |